Kallo Inc. (KALO)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Kallo Inc. (KALO) trades at $0.00. Kallo Inc. develops medical information technology software, including solutions for electronic medical records, disease management, and telehealth. Market cap: $1.91M, Sector: Healthcare.
Last analyzed: Mar 17, 2026Analyst Coverage for KALO: KALO does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates KALO against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
KALO: 1/1 perspectives are bearish.
Kallo Inc. (KALO) Healthcare & Pipeline Overview
Kallo Inc. is a healthcare information technology company focused on developing integrated software solutions for electronic medical records, disease management, and telehealth. With a small team and a portfolio of products in development, Kallo aims to enhance healthcare delivery through technology, operating within the competitive healthcare IT sector.
What Is the Investment Thesis for KALO?
Kallo Inc. presents a high-risk, high-reward investment opportunity within the healthcare IT sector. The company's focus on developing integrated medical information technology solutions, including EMR integration and telehealth platforms, addresses a growing need for efficient healthcare data management and remote patient care. However, with a market capitalization of $0.00B and a small team, Kallo faces significant challenges in commercializing its products and competing with established players. The company's beta of 2.70 indicates high volatility. Success hinges on securing funding, achieving regulatory approvals, and successfully marketing its products to healthcare providers. The negative P/E ratio of -0.08 reflects the company's current lack of profitability.
Based on FMP financials and quantitative analysis
KALO Key Highlights
- Market capitalization of $0.00B, indicating a micro-cap company with high growth potential but also significant risk.
- Beta of 2.70, reflecting high volatility compared to the overall market.
- Negative P/E ratio of -0.08, signaling that the company is currently not profitable.
- Focus on developing Electronic Medical Records (EMR) Integration Engine, addressing a critical need for interoperability in healthcare.
- Development of KIDS Global Tele-Health Ecosystems, positioning the company to capitalize on the growing telehealth market.
Who Are KALO's Competitors?
KALO is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| CARL CARLSMED, INC. | $11.43 | -1.68% | $310.59M | 70 |
| HNGE Hinge Health, Inc. | $65.34 | +0.91% | 6B | 68 |
| VRHI Veri Medtech Holdings Inc. | $1.05 | +7.08% | $21.00M | 67 |
| AKLI Akili, Inc. | $0.43 | +0.25% | $34.10M | 67 |
| CSLT Castlight Health, Inc. | $2.05 | +0.00% | 54 | |
| RCM R1 RCM Inc. | $14.31 | +0.00% | $6.04B | 54 |
| BFRG Bullfrog AI Holdings, Inc. Common Stock | $0.63 | -7.29% | $6.66M | 54 |
| CERN Cerner Corporation | $94.92 | +0.00% | 54 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are KALO's Key Strengths?
- Focus on integrated medical information technology solutions.
- Development of telehealth platforms and mobile clinic technology.
- Proprietary technology such as the KIDS framework.
- Potential for early mover advantage in specialized telehealth segments.
What Are KALO's Weaknesses?
- Limited financial resources and small team size.
- Lack of established market presence and brand recognition.
- Dependence on successful commercialization of products in development.
- High beta indicating significant stock volatility.
What Could Drive KALO Stock Higher?
- Potential partnerships with healthcare providers to implement Kallo's telehealth solutions.
- Regulatory approvals for Kallo's EMR Integration Engine.
- Increasing adoption of telehealth services due to the COVID-19 pandemic.
- Government initiatives promoting electronic health records and interoperability.
What Are the Key Risks for KALO?
- Limited financial resources to compete with larger healthcare IT companies.
- Failure to achieve market acceptance for Kallo's products.
- Cybersecurity threats and data privacy concerns.
- Rapid technological changes and evolving regulatory requirements.
- High stock volatility due to the company's micro-cap status.
What Are the Growth Opportunities for KALO?
- Expansion of Telehealth Services: The global telehealth market is projected to reach $55.6 billion by 2027, growing at a CAGR of 25.8% from 2020. Kallo's MC-Telehealth and KIDS Global Tele-Health Ecosystems position it to capitalize on this growth by providing virtual medical care and patient education. Success depends on expanding its telehealth platform, securing partnerships with healthcare providers, and demonstrating improved patient outcomes.
- EMR Integration Engine Adoption: The market for EMR systems is expected to grow as healthcare providers seek to improve data interoperability and streamline workflows. Kallo's EMR Integration Engine can address this need by connecting various applications within and outside healthcare facilities. Growth depends on demonstrating the engine's compatibility with different EMR systems, ensuring data security, and offering cost-effective integration solutions.
- Disease Management Solutions: The increasing prevalence of chronic and infectious diseases drives the demand for effective disease management solutions. Kallo's Communicable and Infectious Disease Information Management System can help healthcare providers monitor and manage disease information. Growth depends on expanding the system's capabilities to cover a wider range of diseases, integrating it with public health databases, and providing real-time data analytics.
- Global Market Expansion: Kallo can expand its reach by targeting international markets with its telehealth and EMR integration solutions. The global healthcare IT market is expected to grow, particularly in developing countries with limited access to healthcare services. Success depends on adapting its products to meet local regulatory requirements, establishing partnerships with international healthcare providers, and offering multilingual support.
- Strategic Partnerships: Kallo can accelerate its growth by forming strategic partnerships with established healthcare providers, technology companies, and research institutions. These partnerships can provide access to new markets, funding, and expertise. Potential partners include hospitals, clinics, telehealth providers, and EMR vendors. Success depends on identifying mutually beneficial partnerships, negotiating favorable terms, and integrating its solutions with partner platforms.
What Opportunities Does KALO Have?
- Growing demand for telehealth services and remote patient monitoring.
- Increasing adoption of electronic health records and need for interoperability.
- Expansion into international markets with limited access to healthcare.
- Strategic partnerships with established healthcare providers and technology companies.
What Threats Does KALO Face?
- Competition from larger, more established healthcare IT companies.
- Rapid technological changes and evolving regulatory requirements.
- Risk of product obsolescence and failure to achieve market acceptance.
- Potential cybersecurity threats and data privacy concerns.
What Are KALO's Competitive Advantages?
- Proprietary Technology: Kallo's integrated delivery system (KIDS) and telehealth platform represent unique technological solutions.
- Focus on Integration: The EMR Integration Engine provides a crucial service by connecting disparate healthcare systems.
- Early Mover Advantage: Being an early entrant in specialized telehealth segments can create a competitive edge.
What Does KALO Do?
Kallo Inc., formerly known as Diamond Technologies Inc., was incorporated in 2006 and is headquartered in Toronto, Canada. The company focuses on developing medical information technology software designed to improve healthcare delivery and information management. Kallo's product portfolio includes the Electronic Medical Records (EMR) Integration Engine, which connects various applications within and outside healthcare facilities with the EMR system. Other products in development include the Communicable and Infectious Disease Information Management System, an internet-based solution for monitoring and managing disease information, and Clinical-Care Globalization, a technology aimed at expanding clinical care reach. Kallo also offers MC-Telehealth, a mobile clinic with telehealth system technology, and the Kallo Integrated Delivery System (KIDS), a framework that defines the component parts of its products and services. The KIDS Global Tele-Health Ecosystems is a telehealth program encompassing technologies and administrative processes for delivering virtual medical care, health promotion, and patient education. Kallo's focus is on creating integrated systems to streamline healthcare operations and improve patient outcomes.
What Products and Services Does KALO Offer?
- Develop Electronic Medical Records (EMR) Integration Engine software.
- Create Internet-based solutions for managing communicable and infectious disease information.
- Offer Clinical-Care Globalization technology.
- Provide MC-Telehealth, a mobile clinic with telehealth system technology.
- Develop the Kallo Integrated Delivery System (KIDS) technology and process framework.
- Offer KIDS Global Tele-Health Ecosystems, a telehealth program for virtual medical care and patient education.
How Does KALO Make Money?
- Develops and licenses medical information technology software to healthcare providers.
- Offers telehealth solutions and services to patients and healthcare organizations.
- Generates revenue through software licensing fees, subscription fees, and service fees.
What Industry Does KALO Operate In?
Kallo Inc. operates in the healthcare information services industry, a sector experiencing rapid growth due to the increasing adoption of digital health technologies and the need for efficient data management. The market is driven by factors such as government regulations promoting electronic health records, the rising prevalence of chronic diseases, and the growing demand for remote patient monitoring. Kallo competes with larger, more established players like ACNNF (Accenture), CANB (Can B Corp), CBDNF (CBD of Denver Inc), EPWCF (Empower Clinics Inc), and GABLF (Global Asset Backed Lending LLC), as well as smaller niche providers. Success in this market requires continuous innovation, strong regulatory compliance, and effective marketing to healthcare providers.
Who Are KALO's Key Customers?
- Hospitals and clinics seeking to improve their electronic medical record systems.
- Healthcare providers looking to implement telehealth solutions.
- Public health organizations needing to manage communicable and infectious disease information.
- Patients seeking virtual medical care and health education.
KALO Financials
KALO Latest News
No recent news available for KALO.
KALO Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for KALO.
Price Targets
Wall Street price target analysis for KALO.
KALO MoonshotScore
What does this score mean?
The MoonshotScore rates KALO's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: John Cecil
CEO
John Cecil serves as the CEO of Kallo Inc. His background includes experience in managing small teams and overseeing the development of medical information technology software. He is responsible for the strategic direction and overall management of the company. His expertise lies in identifying opportunities within the healthcare IT sector and guiding the company's product development efforts.
Track Record: Under John Cecil's leadership, Kallo Inc. has focused on developing integrated healthcare solutions, including the EMR Integration Engine and the KIDS Global Tele-Health Ecosystems. Key milestones include the development and ongoing refinement of these core products. His focus has been on positioning the company to capitalize on the growing demand for telehealth and interoperable healthcare systems.
KALO OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Kallo Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure and may be subject to greater risks due to less stringent regulatory oversight. Investing in companies on the OTC Other tier carries a higher degree of risk compared to those listed on major exchanges like NYSE or NASDAQ.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure and transparency.
- Higher risk of fraud and manipulation.
- Lower liquidity and wider bid-ask spreads.
- Greater volatility and price fluctuations.
- Potential for delisting or suspension of trading.
- Verify the company's registration and regulatory filings.
- Review the company's financial statements, if available.
- Assess the company's business model and competitive landscape.
- Evaluate the management team's experience and track record.
- Check for any legal or regulatory issues.
- Monitor trading volume and price activity.
- Consult with a financial advisor.
- Company has been in operation since 2006.
- Focus on developing medical information technology software.
- Development of integrated healthcare solutions such as the EMR Integration Engine.
- Presence of a CEO and management team.
What Investors Ask About Kallo Inc. (KALO) — Healthcare
What does Kallo Inc. do?
Kallo Inc. is a healthcare information technology company that develops and markets integrated software solutions for the healthcare industry. Their primary focus is on creating technologies that facilitate the seamless exchange of information between different healthcare systems, improve disease management, and enable telehealth services. The company's products include the Electronic Medical Records (EMR) Integration Engine, the Communicable and Infectious Disease Information Management System, and the KIDS Global Tele-Health Ecosystems. Kallo aims to enhance the efficiency and effectiveness of healthcare delivery through innovative technology solutions.
What do analysts say about KALO stock?
As of March 17, 2026, there is no available analyst coverage for Kallo Inc. (KALO). Given its micro-cap status and OTC listing, the company may not attract significant attention from major research firms. Investors should conduct their own thorough due diligence and consider the company's fundamentals, growth prospects, and risk factors before making any investment decisions. The lack of analyst coverage should be viewed as a factor contributing to the overall risk profile of the stock.
What are the main risks for KALO?
Kallo Inc. faces several significant risks typical of small, developing companies in the healthcare IT sector. These include limited financial resources, intense competition from larger and more established players, the need to navigate complex regulatory requirements, and the potential for rapid technological changes to render their products obsolete. Additionally, as an OTC-listed company, Kallo is subject to greater scrutiny and potential volatility due to lower liquidity and transparency. Investors should carefully consider these risks before investing in KALO.
What are the key factors to evaluate for KALO?
Evaluate KALO on fundamentals, analyst consensus, and risk factors. Not financial advice.
How frequently does KALO data refresh on this page?
KALO prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven KALO's recent stock price performance?
Kallo Inc. (KALO) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Focus on integrated medical information technology solutions. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider KALO overvalued or undervalued right now?
Valuing Kallo Inc. (KALO) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying KALO?
Before investing in Kallo Inc. (KALO), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on publicly available sources and may be limited due to the company's OTC listing and limited financial disclosure.